Loop Genomics uses Illumina's short-read infrastructure and software to generate viral amplicon long reads with only one in 25,000 errors per base pair, enabling strain and quasispecies resolution, according to the company.

Hospitals and public health and reference laboratories can use Loop's long polymerase chain reaction (PCR) amplicon kit with their existing Illumina sequencers to generate SARS-CoV-2 long reads.

The jury is still out for SARS-CoV-2 intermediate host
Scientists have been searching for the intermediate host between bats, which are known to carry coronaviruses, and the first introduction of SARS-CoV-2...

COVID-19 research consortium expands
The EndPandemic National Data Consortium is about to expand by six life sciences and information technology companies.

NIH tests for SARS-CoV-2 antibodies in the general population
The U.S. National Institutes of Health (NIH) has commenced a study to determine how many adults in the U.S. with no confirmed history of infection with...

Scientists explore SARS-CoV-2 main protease as a drug target
A team of researchers report the structure of the main protease of the novel coronavirus and have identified several drugs that show promise in combating...

Eurofins Discovery supports COVID-19 research
Eurofins Discovery has announced that it aims to accelerate COVID-19 antiviral drug discovery research.